際際滷

際際滷Share a Scribd company logo
Pain Management.pdf
DR.SABA NOOR
HOUSEOFFICER
CONTENTS
 INTRODUCTION
 ANATOMY
 PATHOPHYSIOLOGY
 CLASSIFICATION
 TYPES
 EFFECTS OF PAIN
 PAIN ASSESSMENT
 REASSESSMENT OF PAIN
 MANAGEMENT OF PAIN
INTRODUCTION
  Pain is an unpleasant sensory and emotional experience
associated with actual or potential tissue damage, or described in
terms of such damage.
-International Association for the study of pain (Merskey,1979)
Pain is always subjective.
The patient's self-report of pain is the single most reliable indicator
of pain.
CONTI...
 protective mechanism
  localized sensation as a result of noxious stimulation
  now recognized as being more of an experience than a sensation.
ANATOMY OF PAIN
PHYSIOLOGY OF PAIN
 Transduction
 Transmission
 Perception
 Modulation
PATHOPHYSIOLOGY
 Nociceptive pain
 (stimuli from somatic and visceral structures)
 Neuropathic pain
 (stimuli abnormally processed by the nervous system)
NOCICEPTIVE PAIN
 Caused by invasion &/or destruction &/or pressure on superficial
somatic structures like
 skin,
 deeper skeletal structures such as bone & muscle and visceral
structures and organs.
NEUROPATHIC
 Caused by pressure on &/or destruction of peripheral, autonomic
or central nervous system structures.
 Radiation of pain along dermatomal or peripheral nerve
distributions.
 Often described as burning and/or deep aching & associated with
dysesthesia or lancinating pain
CLASSIFICATION ON BASIS OF DURATION
 Transient Pain
 Short duration  Severe  Self limiting
 Acute
  Associated with postoperative, post injury  Requires pharmacological
assistance(analgesics)
 Persistent
  Long term duration  Eg.: Cancer & neurogenic pain  Pharmacological
assistance(analgesics) and cognitive approach
 Chronic or Disabling
  Continue beyond expectation for disease process  Pain and pain therapy
dominate the life  Depression, anxiety Depending On Duration 15
ACUTE PAIN
 Acute pain presents most often with a clear cause, relatively brief
in duration and subsides as healing takes place.
Acute pain is often accompanied by observable objective signs of
pain
increased pulse rate
increased blood pressure
Non-verbal signs and symptoms such as facial expressions and
tense muscles.
CHRONIC PAIN
 Pain that is persistent and recurrent.
When pain persists, it serves no useful purpose and may
dramatically decrease the quality of life and function.
Chronic pain rarely has any observable or behavioral signs
although persons may appear anxious or depressed.
 Somatic
 Visceral
 Bone
 Neuropathic
 Emotional/Spiritual
TYPES OF PAIN
EFFECTS OF PAIN
 Sympathetic responses
 Pallor ,Increased blood pressure
 Increased pulse ,Increased respiration
 Skeletal muscle tension ,Diaphoresis
 Parasympathetic responses
 Decreased blood pressure ,Decreased pulse
 Nausea & vomiting
 Weakness o Pallor o Loss of consciousness
PAIN ASSESSMENT
Pain Histroy
 Pain Assessment Tools
 Verbal Analogue Scales
 Visual Analogue Scales
 The Faces Scale
PAIN HISTORY
 The site of pain
 Type of pain
 Exacerbating & Relieving factors
 How frequently
 Impact on daily life
 What is the response to past and current analgesic therapy?
Pain Management.pdf
Pain Management.pdf
REASSESSMENT
 Every 8 hours minimally
Followinh the admiinistation of pain
Medications to determine the effectiveness of the medication.
Iv within 15 mins of administration
PO/IM/SC within 1 hours of administration
GOALS OF PAIN MANAGEMENT THERAPY
 1) Decreased pain
 2) Decreased healthcare utilization
 o Decreased shopping for care
 o Decreased emergency room visits
 3) Improved functional status
 o Increased ability to perform activities of daily living
  Return to employment
MANAGEMENT
Non-Pharamcological treatment
 Pharmacological treatment:
 Analgesics
 Adjuvants
 Others
NON-PHARMACOLOGICAL INTERVENTIONS
 Exercise
 Weight reduction
 Counseling
 Smoking cessation
 Massage ,Relaxation therapy
 Heat & cold applications
PHARMACOLOGICALINTERVENTIONS
 Analgesics
 Non-opioid e.g. aspirin,paracetamol
 Opioids e.g. codeine, morphine
 Adjuvant e.g. muscle relaxant, antidepressant, anti-epileptic
WHO 3 STEP ANALGESIC LADDER
ACETAMINOPHEN (PARACETAMOL)
 First-line treatment if no contraindication
 Mechanism: thought to inhibit prostaglandin synthesis in CNS
 analgesia, antipyretic
 Typical dose: 650 to 1000mg PO every 6H
 Max dose: 4 g / 24 hrs from all sources
 Warning:  dose / avoid in those with liver damage
NSAIDS
 First-line treatment
 Mechanism
Block cyclooxygenase (COX) enzyme   prostaglandin synthesis
COX-2  Prostaglandins  pain, inflammation, fever
COX-1  Prostaglandins  gastric protection, hemostasis
No physical dependence
No tolerance
NSAID
TRAMADOL
 Multiplemechanism
 Weak 袖-receptoragonist
 Inhibit serotonin& NE reuptake
 Application : Mild to ModeratePost-op pain
 Dose : 50-100mg PO q 4-6 hr.
 Max. 400 mg/d
 Side effect: Nausea and Vomitting
OPIOIDS
Essential element of pain management
Mechanism
Action on opioid receptor
Located mainly in spinal cord & brainstem, some in peripheral
tissue.
STRONG OPIOIDS
 .Agonists :
 stimulate receptor
 no ceiling effect ( no limit mg/kg)
 moderate to severe pain
 Codiene, morphine, pethidine, fentanyl, methadone.
 Partialagonists :
 ceiling effects eg. Buprenorphine
OPIOIDS
 Agonists-antagonists:
 can used in mild to moderate pain
 ceiling effects
 precipitatewithdrawal in opioids dependent
 E.g: Pentazocine, Nalbuphine, Nalorphine
LOCAL ANAESTHETICS
 LA bind sodium channels preventing propagationof action
potentials along nerves
 Wide variety of LA with different characteristics:
 Lidocaine  fast onset, short duration of action
 Bupivacaine  slow onset, longer duration
 Ropivacaine: longer duration, less cardiotoxic
COANALGESIC AGENTS
  Anxiolytic drugs  Anticonvulsants  Antidepressants  Ketamine
 Ketamine  Potent analgesic effect
 Small doses in combination of opioids substantially improve
pain control
 Bolus dose of 100 mcg/kg followed by a continuous drip of 1-3
mcg/kg/min is ideal for chronic opioid users postoperatively
ANTI-EPILEPTIC DRUGS
 in Acute Pain  Every surgical incisional pain has Neuropathic
component Studies showed giving 1200 mg of Gabapent in 1 h
prior to surgery decreases the opioidsrequirement post-op and
result in better pain control without increased sedation
Combining Gabapentin with opioidsis ideal for re-do back
surgery cases with chronic opioidsusage These class of drugs are
also mode stabilizers
CONCLUSION
 Painmanagement is a comprehensive, patient-centered process including
pharmacologicalagent, psychosocialcounseling,and non-pharmacological
treatments when appropriate.
Always start with the lowest dose, least side-effect agents and reassess
frequently with patients input.
Use conversion chart for IV to PO, and this transitionshould be done as
soon as possible.
Only the patient can describe characteristicsand rate the severity of his or
her pain.
All non-opioids medicationhave ceiling effects. Do not combine multiple
NSAIDs.
Use alternative treatments to minimizepotentialside-effects.
Consider adjuvants for specific pains such as bone pain or neuropathic.
When in doubt, always ask for help from the experts.
Pain Management.pdf

More Related Content

Similar to Pain Management.pdf (20)

Analgesic & antipyretic drugs
Analgesic & antipyretic drugsAnalgesic & antipyretic drugs
Analgesic & antipyretic drugs
ZannatunnesaBristi
Pain Relief
Pain ReliefPain Relief
Pain Relief
Soe Myat Thwe
Non steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugsNon steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugs
Snigdha Maity
postoperative pain assessment and management
postoperative pain assessment and managementpostoperative pain assessment and management
postoperative pain assessment and management
propofol2012
PHARMACOLOGY NARCOTIC ANALGESICS
PHARMACOLOGY NARCOTIC ANALGESICSPHARMACOLOGY NARCOTIC ANALGESICS
PHARMACOLOGY NARCOTIC ANALGESICS
DRx Rajveer Prajapati
Post operative pain management
Post operative pain managementPost operative pain management
Post operative pain management
Hriday Ranjan Roy
clase N属: 03 de odontopediatria(semana 3)
clase N属: 03 de odontopediatria(semana 3)clase N属: 03 de odontopediatria(semana 3)
clase N属: 03 de odontopediatria(semana 3)
CarlosAlbertoFarjeGa
Chronic pain assessment & management
Chronic pain assessment & management Chronic pain assessment & management
Chronic pain assessment & management
Shekhar Anand
Pain management novel trends
Pain management   novel trendsPain management   novel trends
Pain management novel trends
Haripriya Uppala
Pain management in cancer
Pain management in cancerPain management in cancer
Pain management in cancer
Nabeel Yahiya
Dolor.pdf
Dolor.pdfDolor.pdf
Dolor.pdf
Raul D-v
Acute and Chronic Pain Managsssement.pptx
Acute and Chronic Pain Managsssement.pptxAcute and Chronic Pain Managsssement.pptx
Acute and Chronic Pain Managsssement.pptx
bijayap1119
6188588.ppt
6188588.ppt6188588.ppt
6188588.ppt
Saumya Singh
N388 analgesics antipyretic-anti-inflammatories rev6 (3)
N388 analgesics antipyretic-anti-inflammatories rev6 (3)N388 analgesics antipyretic-anti-inflammatories rev6 (3)
N388 analgesics antipyretic-anti-inflammatories rev6 (3)
Inna Borukhova
Analgesics
AnalgesicsAnalgesics
Analgesics
Sujit Karpe
Pharmacology of Chronic Pain Treatment Addiction and Risks
Pharmacology of Chronic Pain Treatment Addiction and Risks Pharmacology of Chronic Pain Treatment Addiction and Risks
Pharmacology of Chronic Pain Treatment Addiction and Risks
Michael Changaris
This unbearable pain
This unbearable painThis unbearable pain
This unbearable pain
SpinePlus
Treating postoperative pain
Treating postoperative painTreating postoperative pain
Treating postoperative pain
SpinePlus
managing_surgical_pain.ppt
managing_surgical_pain.pptmanaging_surgical_pain.ppt
managing_surgical_pain.ppt
Helmi978003
managing_surgical_pain.ppt
managing_surgical_pain.pptmanaging_surgical_pain.ppt
managing_surgical_pain.ppt
AjayModgil4
Analgesic & antipyretic drugs
Analgesic & antipyretic drugsAnalgesic & antipyretic drugs
Analgesic & antipyretic drugs
ZannatunnesaBristi
Non steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugsNon steroidal antiinflammatory drugs
Non steroidal antiinflammatory drugs
Snigdha Maity
postoperative pain assessment and management
postoperative pain assessment and managementpostoperative pain assessment and management
postoperative pain assessment and management
propofol2012
Post operative pain management
Post operative pain managementPost operative pain management
Post operative pain management
Hriday Ranjan Roy
clase N属: 03 de odontopediatria(semana 3)
clase N属: 03 de odontopediatria(semana 3)clase N属: 03 de odontopediatria(semana 3)
clase N属: 03 de odontopediatria(semana 3)
CarlosAlbertoFarjeGa
Chronic pain assessment & management
Chronic pain assessment & management Chronic pain assessment & management
Chronic pain assessment & management
Shekhar Anand
Pain management novel trends
Pain management   novel trendsPain management   novel trends
Pain management novel trends
Haripriya Uppala
Pain management in cancer
Pain management in cancerPain management in cancer
Pain management in cancer
Nabeel Yahiya
Dolor.pdf
Dolor.pdfDolor.pdf
Dolor.pdf
Raul D-v
Acute and Chronic Pain Managsssement.pptx
Acute and Chronic Pain Managsssement.pptxAcute and Chronic Pain Managsssement.pptx
Acute and Chronic Pain Managsssement.pptx
bijayap1119
N388 analgesics antipyretic-anti-inflammatories rev6 (3)
N388 analgesics antipyretic-anti-inflammatories rev6 (3)N388 analgesics antipyretic-anti-inflammatories rev6 (3)
N388 analgesics antipyretic-anti-inflammatories rev6 (3)
Inna Borukhova
Pharmacology of Chronic Pain Treatment Addiction and Risks
Pharmacology of Chronic Pain Treatment Addiction and Risks Pharmacology of Chronic Pain Treatment Addiction and Risks
Pharmacology of Chronic Pain Treatment Addiction and Risks
Michael Changaris
This unbearable pain
This unbearable painThis unbearable pain
This unbearable pain
SpinePlus
Treating postoperative pain
Treating postoperative painTreating postoperative pain
Treating postoperative pain
SpinePlus
managing_surgical_pain.ppt
managing_surgical_pain.pptmanaging_surgical_pain.ppt
managing_surgical_pain.ppt
Helmi978003
managing_surgical_pain.ppt
managing_surgical_pain.pptmanaging_surgical_pain.ppt
managing_surgical_pain.ppt
AjayModgil4

Recently uploaded (20)

YSPH VMOC Special Report - Measles Outbreak Southwest US 4-12-2025 2300 hrs ...
YSPH VMOC Special Report - Measles Outbreak  Southwest US 4-12-2025 2300 hrs ...YSPH VMOC Special Report - Measles Outbreak  Southwest US 4-12-2025 2300 hrs ...
YSPH VMOC Special Report - Measles Outbreak Southwest US 4-12-2025 2300 hrs ...
Yale School of Public Health - The Virtual Medical Operations Center (VMOC)
Synthesis for VIth SEM 21-2-25.pptx by Mrs. Manjushri P. Dabhade
Synthesis for VIth SEM 21-2-25.pptx by Mrs. Manjushri P. DabhadeSynthesis for VIth SEM 21-2-25.pptx by Mrs. Manjushri P. Dabhade
Synthesis for VIth SEM 21-2-25.pptx by Mrs. Manjushri P. Dabhade
Dabhade madam Dabhade
Phenomenology - Intro xxxxxxxxxxxxxxxxxx
Phenomenology - Intro xxxxxxxxxxxxxxxxxxPhenomenology - Intro xxxxxxxxxxxxxxxxxx
Phenomenology - Intro xxxxxxxxxxxxxxxxxx
dylanlad67
6th Grade Intro to Algorithms & Programming.pptx
6th Grade Intro to Algorithms & Programming.pptx6th Grade Intro to Algorithms & Programming.pptx
6th Grade Intro to Algorithms & Programming.pptx
Melanie Wood
Pushyabhuti Dynesty Vardhan Vamsha Early Rulers.pptx
Pushyabhuti Dynesty Vardhan Vamsha Early Rulers.pptxPushyabhuti Dynesty Vardhan Vamsha Early Rulers.pptx
Pushyabhuti Dynesty Vardhan Vamsha Early Rulers.pptx
Arya Mahila P. G. College, Banaras Hindu University, Varanasi, India.
Administration of medication.Medication administration: the direct applicatio...
Administration of medication.Medication administration: the direct applicatio...Administration of medication.Medication administration: the direct applicatio...
Administration of medication.Medication administration: the direct applicatio...
DR .PALLAVI PATHANIA
Anthelmintic Agent.pptx by Mrs. Manjushri P. Dabhade
Anthelmintic Agent.pptx by Mrs. Manjushri P. DabhadeAnthelmintic Agent.pptx by Mrs. Manjushri P. Dabhade
Anthelmintic Agent.pptx by Mrs. Manjushri P. Dabhade
Dabhade madam Dabhade
Information Sources & Resource and Various uses_.pptx
Information Sources & Resource and Various uses_.pptxInformation Sources & Resource and Various uses_.pptx
Information Sources & Resource and Various uses_.pptx
Central University of South Bihar, Gaya, Bihar
Rise of Gurjara Pratihars Rajput Dynasty.pptx
Rise of Gurjara Pratihars Rajput Dynasty.pptxRise of Gurjara Pratihars Rajput Dynasty.pptx
Rise of Gurjara Pratihars Rajput Dynasty.pptx
Arya Mahila P. G. College, Banaras Hindu University, Varanasi, India.
FANDOM QUIZ | THE QUIZ CLUB OF PSGCAS .pdf
FANDOM QUIZ | THE QUIZ CLUB OF PSGCAS .pdfFANDOM QUIZ | THE QUIZ CLUB OF PSGCAS .pdf
FANDOM QUIZ | THE QUIZ CLUB OF PSGCAS .pdf
Quiz Club of PSG College of Arts & Science
Combinatorial_Chemistry.pptx by Mrs. Manjushri P. Dabhade
Combinatorial_Chemistry.pptx by Mrs. Manjushri P. DabhadeCombinatorial_Chemistry.pptx by Mrs. Manjushri P. Dabhade
Combinatorial_Chemistry.pptx by Mrs. Manjushri P. Dabhade
Dabhade madam Dabhade
GENERAL QUIZ | QUIZ CLUB OF PSGCAS | 5 AUGUST 2024.pptx
GENERAL QUIZ | QUIZ CLUB OF PSGCAS | 5 AUGUST 2024.pptxGENERAL QUIZ | QUIZ CLUB OF PSGCAS | 5 AUGUST 2024.pptx
GENERAL QUIZ | QUIZ CLUB OF PSGCAS | 5 AUGUST 2024.pptx
Quiz Club of PSG College of Arts & Science
Using social media to learn from conferences
Using social media to learn from conferencesUsing social media to learn from conferences
Using social media to learn from conferences
Sue Beckingham
Developing Topic and Research Question for Systematic Reviews - Emmanuel Ekpor
Developing Topic and Research Question for Systematic Reviews - Emmanuel EkporDeveloping Topic and Research Question for Systematic Reviews - Emmanuel Ekpor
Developing Topic and Research Question for Systematic Reviews - Emmanuel Ekpor
Systematic Reviews Network (SRN)
Anti-Protozoal Agents.pptx by Mrs. Manjushri P. Dabhade
Anti-Protozoal Agents.pptx by Mrs. Manjushri P. DabhadeAnti-Protozoal Agents.pptx by Mrs. Manjushri P. Dabhade
Anti-Protozoal Agents.pptx by Mrs. Manjushri P. Dabhade
Dabhade madam Dabhade
European challenges through ancient lens: revisiting the 'decline' of the Wes...
European challenges through ancient lens: revisiting the 'decline' of the Wes...European challenges through ancient lens: revisiting the 'decline' of the Wes...
European challenges through ancient lens: revisiting the 'decline' of the Wes...
Javier Andreu
Introduction to Sequential Circuits: Flip-Flops, Latches, and State Machines
Introduction to Sequential Circuits: Flip-Flops, Latches, and State MachinesIntroduction to Sequential Circuits: Flip-Flops, Latches, and State Machines
Introduction to Sequential Circuits: Flip-Flops, Latches, and State Machines
GS Virdi
Salesforce Certification Prep Crash Course.pptx
Salesforce Certification Prep Crash Course.pptxSalesforce Certification Prep Crash Course.pptx
Salesforce Certification Prep Crash Course.pptx
Mauricio Alexandre Silva
IB-Unit-5 BBA BVIMR 2022 Syllabus_watermark.pdf
IB-Unit-5 BBA BVIMR 2022 Syllabus_watermark.pdfIB-Unit-5 BBA BVIMR 2022 Syllabus_watermark.pdf
IB-Unit-5 BBA BVIMR 2022 Syllabus_watermark.pdf
Dr. Mahtab Alam
Code a Strategy on Pine Script With the Help of ChatGPT by Akshay Choudhary
Code a Strategy on Pine Script With the Help of ChatGPT by Akshay ChoudharyCode a Strategy on Pine Script With the Help of ChatGPT by Akshay Choudhary
Code a Strategy on Pine Script With the Help of ChatGPT by Akshay Choudhary
QuantInsti
Synthesis for VIth SEM 21-2-25.pptx by Mrs. Manjushri P. Dabhade
Synthesis for VIth SEM 21-2-25.pptx by Mrs. Manjushri P. DabhadeSynthesis for VIth SEM 21-2-25.pptx by Mrs. Manjushri P. Dabhade
Synthesis for VIth SEM 21-2-25.pptx by Mrs. Manjushri P. Dabhade
Dabhade madam Dabhade
Phenomenology - Intro xxxxxxxxxxxxxxxxxx
Phenomenology - Intro xxxxxxxxxxxxxxxxxxPhenomenology - Intro xxxxxxxxxxxxxxxxxx
Phenomenology - Intro xxxxxxxxxxxxxxxxxx
dylanlad67
6th Grade Intro to Algorithms & Programming.pptx
6th Grade Intro to Algorithms & Programming.pptx6th Grade Intro to Algorithms & Programming.pptx
6th Grade Intro to Algorithms & Programming.pptx
Melanie Wood
Administration of medication.Medication administration: the direct applicatio...
Administration of medication.Medication administration: the direct applicatio...Administration of medication.Medication administration: the direct applicatio...
Administration of medication.Medication administration: the direct applicatio...
DR .PALLAVI PATHANIA
Anthelmintic Agent.pptx by Mrs. Manjushri P. Dabhade
Anthelmintic Agent.pptx by Mrs. Manjushri P. DabhadeAnthelmintic Agent.pptx by Mrs. Manjushri P. Dabhade
Anthelmintic Agent.pptx by Mrs. Manjushri P. Dabhade
Dabhade madam Dabhade
Combinatorial_Chemistry.pptx by Mrs. Manjushri P. Dabhade
Combinatorial_Chemistry.pptx by Mrs. Manjushri P. DabhadeCombinatorial_Chemistry.pptx by Mrs. Manjushri P. Dabhade
Combinatorial_Chemistry.pptx by Mrs. Manjushri P. Dabhade
Dabhade madam Dabhade
Using social media to learn from conferences
Using social media to learn from conferencesUsing social media to learn from conferences
Using social media to learn from conferences
Sue Beckingham
Developing Topic and Research Question for Systematic Reviews - Emmanuel Ekpor
Developing Topic and Research Question for Systematic Reviews - Emmanuel EkporDeveloping Topic and Research Question for Systematic Reviews - Emmanuel Ekpor
Developing Topic and Research Question for Systematic Reviews - Emmanuel Ekpor
Systematic Reviews Network (SRN)
Anti-Protozoal Agents.pptx by Mrs. Manjushri P. Dabhade
Anti-Protozoal Agents.pptx by Mrs. Manjushri P. DabhadeAnti-Protozoal Agents.pptx by Mrs. Manjushri P. Dabhade
Anti-Protozoal Agents.pptx by Mrs. Manjushri P. Dabhade
Dabhade madam Dabhade
European challenges through ancient lens: revisiting the 'decline' of the Wes...
European challenges through ancient lens: revisiting the 'decline' of the Wes...European challenges through ancient lens: revisiting the 'decline' of the Wes...
European challenges through ancient lens: revisiting the 'decline' of the Wes...
Javier Andreu
Introduction to Sequential Circuits: Flip-Flops, Latches, and State Machines
Introduction to Sequential Circuits: Flip-Flops, Latches, and State MachinesIntroduction to Sequential Circuits: Flip-Flops, Latches, and State Machines
Introduction to Sequential Circuits: Flip-Flops, Latches, and State Machines
GS Virdi
Salesforce Certification Prep Crash Course.pptx
Salesforce Certification Prep Crash Course.pptxSalesforce Certification Prep Crash Course.pptx
Salesforce Certification Prep Crash Course.pptx
Mauricio Alexandre Silva
IB-Unit-5 BBA BVIMR 2022 Syllabus_watermark.pdf
IB-Unit-5 BBA BVIMR 2022 Syllabus_watermark.pdfIB-Unit-5 BBA BVIMR 2022 Syllabus_watermark.pdf
IB-Unit-5 BBA BVIMR 2022 Syllabus_watermark.pdf
Dr. Mahtab Alam
Code a Strategy on Pine Script With the Help of ChatGPT by Akshay Choudhary
Code a Strategy on Pine Script With the Help of ChatGPT by Akshay ChoudharyCode a Strategy on Pine Script With the Help of ChatGPT by Akshay Choudhary
Code a Strategy on Pine Script With the Help of ChatGPT by Akshay Choudhary
QuantInsti

Pain Management.pdf

  • 3. CONTENTS INTRODUCTION ANATOMY PATHOPHYSIOLOGY CLASSIFICATION TYPES EFFECTS OF PAIN PAIN ASSESSMENT REASSESSMENT OF PAIN MANAGEMENT OF PAIN
  • 4. INTRODUCTION Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. -International Association for the study of pain (Merskey,1979) Pain is always subjective. The patient's self-report of pain is the single most reliable indicator of pain.
  • 5. CONTI... protective mechanism localized sensation as a result of noxious stimulation now recognized as being more of an experience than a sensation.
  • 7. PHYSIOLOGY OF PAIN Transduction Transmission Perception Modulation
  • 8. PATHOPHYSIOLOGY Nociceptive pain (stimuli from somatic and visceral structures) Neuropathic pain (stimuli abnormally processed by the nervous system)
  • 9. NOCICEPTIVE PAIN Caused by invasion &/or destruction &/or pressure on superficial somatic structures like skin, deeper skeletal structures such as bone & muscle and visceral structures and organs.
  • 10. NEUROPATHIC Caused by pressure on &/or destruction of peripheral, autonomic or central nervous system structures. Radiation of pain along dermatomal or peripheral nerve distributions. Often described as burning and/or deep aching & associated with dysesthesia or lancinating pain
  • 11. CLASSIFICATION ON BASIS OF DURATION Transient Pain Short duration Severe Self limiting Acute Associated with postoperative, post injury Requires pharmacological assistance(analgesics) Persistent Long term duration Eg.: Cancer & neurogenic pain Pharmacological assistance(analgesics) and cognitive approach Chronic or Disabling Continue beyond expectation for disease process Pain and pain therapy dominate the life Depression, anxiety Depending On Duration 15
  • 12. ACUTE PAIN Acute pain presents most often with a clear cause, relatively brief in duration and subsides as healing takes place. Acute pain is often accompanied by observable objective signs of pain increased pulse rate increased blood pressure Non-verbal signs and symptoms such as facial expressions and tense muscles.
  • 13. CHRONIC PAIN Pain that is persistent and recurrent. When pain persists, it serves no useful purpose and may dramatically decrease the quality of life and function. Chronic pain rarely has any observable or behavioral signs although persons may appear anxious or depressed.
  • 14. Somatic Visceral Bone Neuropathic Emotional/Spiritual TYPES OF PAIN
  • 15. EFFECTS OF PAIN Sympathetic responses Pallor ,Increased blood pressure Increased pulse ,Increased respiration Skeletal muscle tension ,Diaphoresis Parasympathetic responses Decreased blood pressure ,Decreased pulse Nausea & vomiting Weakness o Pallor o Loss of consciousness
  • 16. PAIN ASSESSMENT Pain Histroy Pain Assessment Tools Verbal Analogue Scales Visual Analogue Scales The Faces Scale
  • 17. PAIN HISTORY The site of pain Type of pain Exacerbating & Relieving factors How frequently Impact on daily life What is the response to past and current analgesic therapy?
  • 20. REASSESSMENT Every 8 hours minimally Followinh the admiinistation of pain Medications to determine the effectiveness of the medication. Iv within 15 mins of administration PO/IM/SC within 1 hours of administration
  • 21. GOALS OF PAIN MANAGEMENT THERAPY 1) Decreased pain 2) Decreased healthcare utilization o Decreased shopping for care o Decreased emergency room visits 3) Improved functional status o Increased ability to perform activities of daily living Return to employment
  • 22. MANAGEMENT Non-Pharamcological treatment Pharmacological treatment: Analgesics Adjuvants Others
  • 23. NON-PHARMACOLOGICAL INTERVENTIONS Exercise Weight reduction Counseling Smoking cessation Massage ,Relaxation therapy Heat & cold applications
  • 24. PHARMACOLOGICALINTERVENTIONS Analgesics Non-opioid e.g. aspirin,paracetamol Opioids e.g. codeine, morphine Adjuvant e.g. muscle relaxant, antidepressant, anti-epileptic
  • 25. WHO 3 STEP ANALGESIC LADDER
  • 26. ACETAMINOPHEN (PARACETAMOL) First-line treatment if no contraindication Mechanism: thought to inhibit prostaglandin synthesis in CNS analgesia, antipyretic Typical dose: 650 to 1000mg PO every 6H Max dose: 4 g / 24 hrs from all sources Warning: dose / avoid in those with liver damage
  • 27. NSAIDS First-line treatment Mechanism Block cyclooxygenase (COX) enzyme prostaglandin synthesis COX-2 Prostaglandins pain, inflammation, fever COX-1 Prostaglandins gastric protection, hemostasis No physical dependence No tolerance
  • 28. NSAID
  • 29. TRAMADOL Multiplemechanism Weak 袖-receptoragonist Inhibit serotonin& NE reuptake Application : Mild to ModeratePost-op pain Dose : 50-100mg PO q 4-6 hr. Max. 400 mg/d Side effect: Nausea and Vomitting
  • 30. OPIOIDS Essential element of pain management Mechanism Action on opioid receptor Located mainly in spinal cord & brainstem, some in peripheral tissue.
  • 31. STRONG OPIOIDS .Agonists : stimulate receptor no ceiling effect ( no limit mg/kg) moderate to severe pain Codiene, morphine, pethidine, fentanyl, methadone. Partialagonists : ceiling effects eg. Buprenorphine
  • 32. OPIOIDS Agonists-antagonists: can used in mild to moderate pain ceiling effects precipitatewithdrawal in opioids dependent E.g: Pentazocine, Nalbuphine, Nalorphine
  • 33. LOCAL ANAESTHETICS LA bind sodium channels preventing propagationof action potentials along nerves Wide variety of LA with different characteristics: Lidocaine fast onset, short duration of action Bupivacaine slow onset, longer duration Ropivacaine: longer duration, less cardiotoxic
  • 34. COANALGESIC AGENTS Anxiolytic drugs Anticonvulsants Antidepressants Ketamine Ketamine Potent analgesic effect Small doses in combination of opioids substantially improve pain control Bolus dose of 100 mcg/kg followed by a continuous drip of 1-3 mcg/kg/min is ideal for chronic opioid users postoperatively
  • 35. ANTI-EPILEPTIC DRUGS in Acute Pain Every surgical incisional pain has Neuropathic component Studies showed giving 1200 mg of Gabapent in 1 h prior to surgery decreases the opioidsrequirement post-op and result in better pain control without increased sedation Combining Gabapentin with opioidsis ideal for re-do back surgery cases with chronic opioidsusage These class of drugs are also mode stabilizers
  • 36. CONCLUSION Painmanagement is a comprehensive, patient-centered process including pharmacologicalagent, psychosocialcounseling,and non-pharmacological treatments when appropriate. Always start with the lowest dose, least side-effect agents and reassess frequently with patients input. Use conversion chart for IV to PO, and this transitionshould be done as soon as possible. Only the patient can describe characteristicsand rate the severity of his or her pain. All non-opioids medicationhave ceiling effects. Do not combine multiple NSAIDs. Use alternative treatments to minimizepotentialside-effects. Consider adjuvants for specific pains such as bone pain or neuropathic. When in doubt, always ask for help from the experts.